4Torrns JI,Skumick J. Davidow AL,et al. Ethnic differences in insulin sensitivity and beta - cell function in premenopausal or early perimenopausal women without diabetes:the Study of Women Health Across the Nation (SWAN). Diabetes Care 2004 ;27:354 - 361.
6Clarke PM. Glaszigu P,Paml A,et al. Event rams,hospital utili-zation, and costs associated with malor complications of diabetes:a mu- hicountry comparative analysis. PLoS Med 2010 ;7 :e1000236.
7UK Prospective Diabetes Study ( UKPDS ) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional Ixeatnlent and risk of complications in patients with type 2diabetes( UKPDS 33 ). Lancet 1998 ;352:837 - 853.
8Holman RR. Paul SK. Bethel MA,et al. 10 - year follow - up Of intensive glucose control in type 2 diabetes. N Engl J Med 2008 ; 359:1577 - 1589.
9ADVANCE Collaborative Group. Intensive blood glucose con- trol and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 ;358:2560 -2572.
2Osei K, Rhinesmith S, Gaillard T. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans. Diabetes Care,2004,27 : 1439-1446.
3Li GW, Lillioja S, Peter H, et al. Introduction of a new index of insulin sensitivity. In proceedings of the 15^th international Diabetes Federation Congress, Kobe, Japan, 1994. (Abstract) 1994, p489.
4Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1987,28: 412.
5Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the seven risk of non-insulin dependent diabetes meUitus in Mexican Americans. Diabetes, 1995,44 : 1386,1995.
6Weyer C, Bogardus C, Mott DM, et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest, 1999,104:787-794.
7Lebovitz HE. Type 2 diabetes: an overview. Clin Chem, 1999,45: 1339-1345.
8Zavaronl I , Bonini I. Hypefinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes meUitus: the Barilla factory revisited. Metabolism, 1999,48:984-994.
9Tripathy D , Carisson M. Insulin secretion and insulin sensitivity in relation to glucose tolerance. Diabetes,2000,49:975-980.
